No Data
No Data
Weihua New Materials (603310.SH) distributed 0.4 yuan per share in the first half of the year, with the record date for equity being October 22nd.
Weihua New Materials (603310.SH) announced that the company will implement the interim equity distribution for the first half of 2024, with a distribution per share...
Zhejiang Weihua New Material Appoints Vice Chairman, General Manager
Weihua New Material (603310.SH): Appoints Xia Weiping as the general manager.
Weihua New Material (603310.SH) announced that the board of directors of the company has agreed to elect Pan Qiangbiao as the vice chairman of the company, and ...
Weihua New Materials (603310.SH): Some products can be used for the production of pharmaceutical products.
Weihua New Materials (603310.SH) stated on the investor interaction platform on September 10 that some of the company's products can be used in the production of pharmaceutical products, such as antidepressants, prostate cancer drugs, anti-inflammatory and analgesic drugs, etc. Chlorotoluene is a basic raw material for bulk pharmaceutical products. For example, ortho-chlorotoluene is used in the production of ortho-chlorobenzonitrile, and ortho-chlorobenzonitrile and para-chlorotoluene are key raw materials of sartan drugs. Dichlorotrifluoromethylbenzene, meta-trifluoromethylaniline, etc. also have pharmaceutical uses. However, the pharmaceutical quantity is relatively small and the overall sales proportion is not large. We will continue to develop downstream products for pharmaceuticals, pesticides, dyes, and new materials to reflect a complete production.
2024 Semi-Annual Report
2024 Semi-Annual Report Summary
No Data
No Data